Clinical Trials Browser

Active not recruiting × iberdomide × 90 days × Clear all

NCT05434689 2026-04-15

COMMANDER

Phase 1/2 Active not recruiting

Multiple Myeloma

NCT04975997 2026-04-03

EXCALIBER-RRMM

Phase 3 Active not recruiting

Multiple Myeloma

NCT02773030 2026-03-20

A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

Phase 1/2 Active not recruiting

466 enrolled 57 charts

Multiple Myeloma, Recurrence